Fast and Slow Bone Losers
- 1 January 1998
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 12 (1), 1-7
- https://doi.org/10.2165/00002512-199812001-00001
Abstract
A low bone mineral density (BMD) is presently regarded as the most important risk factor for the development of osteoporosis. BMD is a function of peak bone mass attained during growth and subsequent age-related bone loss. BMD can be measured accurately and precisely, although the rate of bone loss is more difficult to assess. When axial BMD was measured, the rate of bone loss was shown to increase by 2- to 4-fold at the menopause. Although this rate varies markedly between individuals, it is symmetrically distributed, which argues against the existence of a subpopulation of fast bone losers. Levels of biochemical markers of bone turnover (e.g. osteocalcin, bone specific alkaline phosphatase, deoxypyridinoline) also increase markedly at the menopause, and individuals with a high turnover tend to lose bone more rapidly. Moreover, since increased bone resorption also results in qualitative changes regardless of BMD, a high bone turnover constitutes an independent risk factor. Currently, large intra-individual variations (10 to 40%) in levels of biochemical markers and assay errors still limit our ability to correctly classify individual patients as fast or slow bone losers. The routine use of these markers as a screening tool to predict the risk of osteoporosis in individuals is of limited value, although their selective use in therapeutic decision-making is more promising.Keywords
This publication has 40 references indexed in Scilit:
- Highly Precise Peripheral Quantitative Computed Tomography for the Evaluation of Bone Density, Loss of Bone Density and StructuresDrugs & Aging, 1998
- Relationship of Bone Turnover to Bone Density and FracturesJournal of Bone and Mineral Research, 1997
- Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacyBone, 1996
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO reportOsteoporosis International, 1994
- Architecture and vertebral fractureCalcified Tissue International, 1993
- Perimenopausal appendicular bone loss: A 10-year prospective studyBone, 1990
- The contribution of bone loss to postmenopausal osteoporosisOsteoporosis International, 1990
- Age and bone mass as predictors of fracture in a prospective study.JCI Insight, 1988
- Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.JCI Insight, 1983
- Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with ageCalcified Tissue International, 1978